Baluch Khoso Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$211,097.27
Insider Sells Quantity
1
Insider Sells Sum
$2,588.13

Insider Activity of Baluch Khoso

According to the SEC Form 4 filings, Baluch Khoso, being in a position of

  1. director at Processa Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 2269 shares for $5,752, and sold 0 shares,
    over all time since 2026-03-31, has bought 2269 shares for $5,752, and sold 0 shares.

Biography of Baluch Khoso

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$5,7521100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-03-31PurchaseProcessa Pharmaceuticals, Inc.
PCSA
director
2,269
0.1005%
$2.54$5,752-15.02%
2025-08-11PurchaseLongeveron Inc.
LGVN
director
11,766
–
$0$0+7.91%
2024-12-02SaleLongeveron Inc.
LGVN
director
1,250
0.0084%
$2.07$2,588-32.04%
2023-12-29PurchaseLongeveron Inc.
LGVN
director
8,322
0.0349%
$1.43$11,915-84.15%
2023-12-28PurchaseLongeveron Inc.
LGVN
director
1,678
0.0068%
$1.40$2,342-84.46%
2020-08-13PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
4,830
0.0162%
$4.14$19,985+78.66%
2020-03-18PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
3,500
0.0149%
$2.61$9,135+146.38%
2019-03-26PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
2,500
0.0107%
$7.55$18,875-15.66%
2018-11-27PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
21,500
0.0243%
$1.21$26,015+33.33%
2018-11-26PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
3,500
0.0039%
$1.28$4,480+23.08%
2017-12-12PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
104,166
0.1531%
$0.48$50,000-22.03%
2017-08-18PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
36,207
0.0593%
$0.41$15,026+4.76%
2017-05-17PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
75,000
0.1462%
$0.47$35,625-4.35%
2016-12-09PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
10,000
0.0268%
$1.77$17,700-67.82%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.